[3] [4] Despite its limited efficacy, AOD9604 is still banned in athletes and tested for in competition
Research shows that the peptide activates a VEGF-independent pathway for nitric oxide production through Src kinase phosphorylation
Many patients notice improvements in pain, inflammation, and mobility within 1-3 weeks of starting BPC/TB-5 therapy
This is where expectations meet reality
"Insulin resistance and endothelial function are improved after folate and vitamin B12 therapy in patients with metabolic syndrome: relationship between homocysteine levels and hyperinsulinemia"
Whether peptides are prescribed for recovery, metabolic health, body composition, or performance, how they are handled plays a major role in both safety and effectiveness